PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation

Breast Cancer Research and Treatment
Le ZhangErina Vlashi

Abstract

Radiotherapy (RT) constitutes an important part of breast cancer treatment. However, triple negative breast cancers (TNBC) exhibit remarkable resistance to most therapies, including RT. Developing new ways to radiosensitize TNBC cells could result in improved patient outcomes. The M2 isoform of pyruvate kinase (PK-M2) is believed to be responsible for the re-wiring of cancer cell metabolism after oxidative stress. The aim of the study was to determine the effect of ionizing radiation (IR) on PK-M2-mediated metabolic changes in TNBC cells, and their survival. In addition, we determine the effect of PK-M2 activators on breast cancer stem cells, a radioresistant subpopulation of breast cancer stem cells. Glucose uptake, lactate production, and glutamine consumption were assessed. The cellular localization of PK-M2 was evaluated by western blot and confocal microscopy. The small molecule activator of PK-M2, TEPP46, was used to promote its pyruvate kinase function. Finally, effects on cancer stem cell were evaluated via sphere forming capacity. Exposure of TNBC cells to IR increased their glucose uptake and lactate production. As expected, PK-M2 expression levels also increased, especially in the nucleus, although overall pyruvate k...Continue Reading

References

Oct 29, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C ColussiL Ghibelli
May 25, 2002·The Biochemical Journal·Claire Le GoffeChristian L Laboisse
May 21, 2003·Genes & Development·Gabriela DontuMax S Wicha
Dec 21, 2006·Journal of the National Cancer Institute·Tiffany M PhillipsFrank Pajonk
Jan 5, 2007·Proceedings of the National Academy of Sciences of the United States of America·Wendy A WoodwardJeffrey M Rosen
Dec 25, 2007·Journal of Biology·Markus RalserSylvia Krobitsch
Jan 15, 2008·The International Journal of Biochemistry & Cell Biology·Jungwoon LeeJungho Kim
Jan 30, 2008·Journal of Biology·Chris M Grant
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cornelia LiedtkeLajos Pusztai
Mar 14, 2008·Nature·Heather R ChristofkLewis C Cantley
Feb 12, 2009·International Journal of Radiation Biology·Peter O'Neill, Peter Wardman
Feb 27, 2009·Journal of the National Cancer Institute·Erina VlashiFrank Pajonk
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Jul 10, 2009·Nature Biotechnology·Markus RalserCornelis Jakobs
Mar 7, 1927·The Journal of General Physiology·O WarburgE Negelein
Feb 6, 2010·Stem Cells·Frank PajonkWilliam H McBride
Apr 8, 2010·Free Radical Research·Geou-Yarh Liou, Peter Storz
Sep 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Erina VlashiFrank Pajonk
Sep 21, 2011·The Prostate·Lorenza Della DonnaFrank Pajonk
Feb 7, 2012·Molecular Cell·Xueliang GaoZhi-Ren Liu
Apr 11, 2012·Stem Cells·Chann LagadecFrank Pajonk
May 26, 2012·Trends in Biochemical Sciences·Barbara Chaneton, Eyal Gottlieb
Aug 28, 2012·Nature Chemical Biology·Dimitrios AnastasiouMatthew G Vander Heiden
Oct 16, 2012·Nature·Barbara ChanetonEyal Gottlieb
Oct 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mayumi TamadaHideyuki Saya
Mar 1, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shunsuke MuramatsuShigeki Arii
Sep 10, 2013·Cell Cycle·Weiwei Yang, Zhimin Lu
Sep 10, 2013·Breast Cancer Research and Treatment·Erina VlashiFrank Pajonk
Dec 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·Hung-Jung WangWen-Ching Wang
Jul 11, 2014·Breast Cancer Research and Treatment·Erina VlashiFrank Pajonk
Jul 16, 2014·Seminars in Cancer Biology·Erina Vlashi, Frank Pajonk
Oct 2, 2014·International Journal of Oncology·Kazuhiko HayashiKazuhiko Ogawa
Oct 2, 2014·International Journal of Oncology·Keisuke TamariKazuhiko Ogawa
Dec 17, 2014·Stem Cell Reports·Binwu TangLalage M Wakefield
Aug 25, 2015·Molecular Cell·Aaron M HosiosMatthew G Vander Heiden
Oct 24, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zheng ZhaoChengxue Dang
Nov 26, 2015·Oncogene·L JinS Kang
Nov 3, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Koji MunakataMasaki Mori

❮ Previous
Next ❯

Citations

May 29, 2021·Molecular Biology Reports·J R Dev ArundhathiChandra Prakash Prasad
Jul 13, 2021·JCO Precision Oncology·Andrea M PeschCorey W Speers
Jun 30, 2021·Cancer Research·Maria ApostolidiJesse Rinehart
Aug 24, 2021·Frontiers in Physiology·Shuangyan YaoShiheng An

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

Future Medicinal Chemistry
Steven L WarnerDavid J Bearss
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Zheng ZhaoChengxue Dang
Cancer & Metabolism
Allison N LauMatthew G Vander Heiden
© 2021 Meta ULC. All rights reserved